Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for site- 1- protease
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
Most Relevant Literature
- Involvement of Band3 in the efflux of sphingosine 1-phosphate from erythrocytes.
- Ceramide synthase 2 facilitates S1P-dependent egress of thymocytes into the circulation in mice.
- Sphingosine-1-Phosphate Mediates Fibrosis in Orbital Fibroblasts in Graves' Orbitopathy.
- A sphingosine 1-phosphate receptor agonist ameliorates animal model of vasculitis.
- A case of MBTPS1-related disorder due to compound heterozygous variants in MBTPS1 gene: Genotype-phe…
Most Relevant Clinical Trials
- Kaletra: Therapy With Double Protease Inhibitors
- STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19
- Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( C…
- BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patien…
- A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Proteas…
